Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
Semantic Laundering in AI Agent Architectures: Why Tool Boundaries Do Not Confer Epistemic Warrant
arXiv:2601.08333v1 Announce Type: new Abstract: LLM-based agent architectures systematically conflate information transport mechanisms with epistemic justification mechanisms. We formalize this class of architectural failures as semantic laundering: a pattern where propositions with absent or weak warrant are accepted by the system as admissible by crossing architecturally trusted interfaces. We show that semantic laundering constitutes an architectural realization of the Gettier problem: propo
-
cs.AI, q-bio.NC updates on arXiv.org
-
Why AI Alignment Failure Is Structural: Learned Human Interaction Structures and AGI as an Endogenous Evolutionary Shock
arXiv:2601.08673v1 Announce Type: new Abstract: Recent reports of large language models (LLMs) exhibiting behaviors such as deception, threats, or blackmail are often interpreted as evidence of alignment failure or emergent malign agency. We argue that this interpretation rests on a conceptual error. LLMs do not reason morally; they statistically internalize the record of human social interaction, including laws, contracts, negotiations, conflicts, and coercive arrangements. Behaviors commonly
Why AI Alignment Failure Is Structural: Learned Human Interaction Structures and AGI as an Endogenous Evolutionary Shock
-
cs.AI, q-bio.NC updates on arXiv.org
-
ISLA: A U-Net for MRI-based acute ischemic stroke lesion segmentation with deep supervision, attention, domain adaptation, and ensemble learning
arXiv:2601.08732v1 Announce Type: cross Abstract: Accurate delineation of acute ischemic stroke lesions in MRI is a key component of stroke diagnosis and management. In recent years, deep learning models have been successfully applied to the automatic segmentation of such lesions. While most proposed architectures are based on the U-Net framework, they primarily differ in their choice of loss functions and in the use of deep supervision, residual connections, and attention mechanisms. Moreover,
ISLA: A U-Net for MRI-based acute ischemic stroke lesion segmentation with deep supervision, attention, domain adaptation, and ensemble learning
-
cs.AI, q-bio.NC updates on arXiv.org
-
Focus, Merge, Rank: Improved Question Answering Based on Semi-structured Knowledge Bases
arXiv:2505.09246v2 Announce Type: replace-cross Abstract: In many real-world settings, machine learning models and interactive systems have access to both structured knowledge, e.g., knowledge graphs or tables, and unstructured content, e.g., natural language documents. However, most rely on either. Semi-Structured Knowledge Bases (SKBs) bridge this gap by linking unstructured content to nodes within structured data, thereby enabling new strategies for knowledge access and use. In this work, we
Focus, Merge, Rank: Improved Question Answering Based on Semi-structured Knowledge Bases
-
cs.AI, q-bio.NC updates on arXiv.org
-
Aligning Trustworthy AI with Democracy: A Dual Taxonomy of Opportunities and Risks
arXiv:2505.13565v2 Announce Type: replace-cross Abstract: Artificial Intelligence (AI) poses both significant risks and valuable opportunities for democratic governance. This paper introduces a dual taxonomy to evaluate AI's complex relationship with democracy: the AI Risks to Democracy (AIRD) taxonomy, which identifies how AI can undermine core democratic principles such as autonomy, fairness, and trust; and the AI's Positive Contributions to Democracy (AIPD) taxonomy, which highlights AI's po
Aligning Trustworthy AI with Democracy: A Dual Taxonomy of Opportunities and Risks
-
TechCrunch
-
Microsoft announces glut of new data centers but says it won’t let your electricity bill go up
The tech giant has pledged to be a "good neighbor" as it continues to invest in AI infrastructure throughout the country.
Microsoft announces glut of new data centers but says it won’t let your electricity bill go up
-
InfoQ

-
Google Introduces Conductor, a Context-Driven Development Extension for Gemini CLI
Google has released Conductor, a new preview extension for Gemini CLI that introduces a structured, context-driven approach to AI-assisted software development. The extension is designed to address a common limitation of chat-based coding tools: the loss of project context across sessions. By Robert Krzaczyński
Google Introduces Conductor, a Context-Driven Development Extension for Gemini CLI
Google has released Conductor, a new preview extension for Gemini CLI that introduces a structured, context-driven approach to AI-assisted software development. The extension is designed to address a common limitation of chat-based coding tools: the loss of project context across sessions.
By Robert Krzaczyński-
cs.AI, q-bio.NC updates on arXiv.org
-
ConSensus: Multi-Agent Collaboration for Multimodal Sensing
arXiv:2601.06453v1 Announce Type: new Abstract: Large language models (LLMs) are increasingly grounded in sensor data to perceive and reason about human physiology and the physical world. However, accurately interpreting heterogeneous multimodal sensor data remains a fundamental challenge. We show that a single monolithic LLM often fails to reason coherently across modalities, leading to incomplete interpretations and prior-knowledge bias. We introduce ConSensus, a training-free multi-agent col
ConSensus: Multi-Agent Collaboration for Multimodal Sensing
-
cs.AI, q-bio.NC updates on arXiv.org
-
A Large-Scale Study on the Development and Issues of Multi-Agent AI Systems
arXiv:2601.07136v1 Announce Type: cross Abstract: The rapid emergence of multi-agent AI systems (MAS), including LangChain, CrewAI, and AutoGen, has shaped how large language model (LLM) applications are developed and orchestrated. However, little is known about how these systems evolve and are maintained in practice. This paper presents the first large-scale empirical study of open-source MAS, analyzing over 42K unique commits and over 4.7K resolved issues across eight leading systems. Our ana
A Large-Scale Study on the Development and Issues of Multi-Agent AI Systems
-
cs.AI, q-bio.NC updates on arXiv.org
-
app.build: A Production Framework for Scaling Agentic Prompt-to-App Generation with Environment Scaffolding
arXiv:2509.03310v2 Announce Type: replace Abstract: We present app.build (https://github.com/neondatabase/appdotbuild-agent), an open-source framework that improves LLM-based application generation through systematic validation and structured environments. Our approach combines multi-layered validation pipelines, stack-specific orchestration, and model-agnostic architecture, implemented across three reference stacks. Through evaluation on 30 generation tasks, we demonstrate that comprehensive v
app.build: A Production Framework for Scaling Agentic Prompt-to-App Generation with Environment Scaffolding
-
Journal of Medical Internet Research
-
Key Information Influencing Patient Decision-Making About AI in Health Care: Survey Experiment Study
Background: Artificial Intelligence (AI)-enabled devices are increasingly used in healthcare. However, there has been limited research on patients’ informational preferences, including which elements of AI device labeling enhance patient understanding, trust, and acceptance. Clear and effective patient-facing communication is essential to address patient concerns and support informed decision-making regarding AI-enabled care. Objective: Using simulated AI device labels in a cardiovascular contex
Key Information Influencing Patient Decision-Making About AI in Health Care: Survey Experiment Study
-
InfoQ

-
FACTS Benchmark Suite Introduced to Evaluate Factual Accuracy of Large Language Models
A new industry benchmark aimed at systematically evaluating the factual accuracy of LLMs has been released with the launch of the FACTS Benchmark Suite. Developed by the FACTS team in collaboration with Kaggle, the suite expands earlier work on factual grounding and introduces a broader, multi-dimensional framework for measuring how reliably language models produce factually correct responses. By Robert Krzaczyński
FACTS Benchmark Suite Introduced to Evaluate Factual Accuracy of Large Language Models
A new industry benchmark aimed at systematically evaluating the factual accuracy of LLMs has been released with the launch of the FACTS Benchmark Suite. Developed by the FACTS team in collaboration with Kaggle, the suite expands earlier work on factual grounding and introduces a broader, multi-dimensional framework for measuring how reliably language models produce factually correct responses.
By Robert Krzaczyński-
Nature Medicine
-
Interpretable inflammation landscape of circulating immune cells
Nature Medicine, Published online: 12 January 2026; doi:10.1038/s41591-025-04126-3Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.
Interpretable inflammation landscape of circulating immune cells
Nature Medicine, Published online: 12 January 2026; doi:10.1038/s41591-025-04126-3
Including data from 1,047 patients across 19 inflammatory diseases, a new atlas presents a comprehensive model of inflammation in circulating immune cells.-
cs.AI, q-bio.NC updates on arXiv.org
-
The Evaluation Gap in Medicine, AI and LLMs: Navigating Elusive Ground Truth & Uncertainty via a Probabilistic Paradigm
arXiv:2601.05500v1 Announce Type: new Abstract: Benchmarking the relative capabilities of AI systems, including Large Language Models (LLMs) and Vision Models, typically ignores the impact of uncertainty in the underlying ground truth answers from experts. This ambiguity is particularly consequential in medicine where uncertainty is pervasive. In this paper, we introduce a probabilistic paradigm to theoretically explain how high certainty in ground truth answers is almost always necessary for e
The Evaluation Gap in Medicine, AI and LLMs: Navigating Elusive Ground Truth & Uncertainty via a Probabilistic Paradigm
-
cs.AI, q-bio.NC updates on arXiv.org
-
Benchmarking LLM-based Agents for Single-cell Omics Analysis
arXiv:2508.13201v2 Announce Type: replace-cross Abstract: The surge in multimodal single-cell omics data exposes limitations in traditional, manually defined analysis workflows. AI agents offer a paradigm shift, enabling adaptive planning, executable code generation, traceable decisions, and real-time knowledge fusion. However, the lack of a comprehensive benchmark critically hinders progress. We introduce a novel benchmarking evaluation system to rigorously assess agent capabilities in single-
Benchmarking LLM-based Agents for Single-cell Omics Analysis
-
STAT

-
Opinion: The NIH has lost its scientific integrity. So we left
We are National Institutes of Health scientists and administrators with more than 50 years of collective civil service. Or, more accurately, we were NIH scientists and administrators.Read the rest…
Opinion: The NIH has lost its scientific integrity. So we left
We are National Institutes of Health scientists and administrators with more than 50 years of collective civil service.
Or, more accurately, we were NIH scientists and administrators.


© Adobe
-
MRD
-
Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making
Cancers (Basel). 2025 Dec 27;18(1):94. doi: 10.3390/cancers18010094.ABSTRACTPancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor long-term survival despite advances in surgical techniques, systemic therapies, and perioperative management. High rates of systemic recurrence following curative-intent resection suggest that many patients harbor minimal residual disease (MRD), microscopic tumor burden that persists postoperatively and remains undetectable by conventiona
Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making
Cancers (Basel). 2025 Dec 27;18(1):94. doi: 10.3390/cancers18010094.
ABSTRACT
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with poor long-term survival despite advances in surgical techniques, systemic therapies, and perioperative management. High rates of systemic recurrence following curative-intent resection suggest that many patients harbor minimal residual disease (MRD), microscopic tumor burden that persists postoperatively and remains undetectable by conventional diagnostic tools. Recent advances in liquid biopsy technologies, particularly circulating tumor DNA (ctDNA) analysis, alongside detailed characterization of the PDAC mutational landscape, offer a promising non-invasive approach for MRD detection. Emerging evidence indicates that MRD status can serve as a sensitive prognostic biomarker, identify patients at high risk of relapse, and guide personalized perioperative therapy, including optimization of adjuvant treatment. This review summarizes current knowledge on the biology and detection of MRD in PDAC, its implications for perioperative risk stratification and treatment decision-making, and discusses future directions for integrating MRD assessment into clinical practice to enable more precise, individualized patient management.
PMID:41514607 | PMC:PMC12784771 | DOI:10.3390/cancers18010094
-
Nature Medicine
-
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-zAnalysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04170-z
Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.-
Nature Medicine
-
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04171-yIn a randomized, double-blind, placebo-controlled trial comparing autologous mRNA-engineered BCMA-targeting CAR T cell therapy versus placebo in patients with generalized myasthenia gravis, a significantly higher percentage of patients exhibited a reduction in disease activity in the treatment arm than in the placebo arm.
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Nature Medicine, Published online: 09 January 2026; doi:10.1038/s41591-025-04171-y
In a randomized, double-blind, placebo-controlled trial comparing autologous mRNA-engineered BCMA-targeting CAR T cell therapy versus placebo in patients with generalized myasthenia gravis, a significantly higher percentage of patients exhibited a reduction in disease activity in the treatment arm than in the placebo arm.-
cs.AI, q-bio.NC updates on arXiv.org
-
Sci-Reasoning: A Dataset Decoding AI Innovation Patterns
arXiv:2601.04577v1 Announce Type: new Abstract: While AI innovation accelerates rapidly, the intellectual process behind breakthroughs -- how researchers identify gaps, synthesize prior work, and generate insights -- remains poorly understood. The lack of structured data on scientific reasoning hinders systematic analysis and development of AI research agents. We introduce Sci-Reasoning, the first dataset capturing the intellectual synthesis behind high-quality AI research. Using community-vali